JP2023507033A5 - - Google Patents
Info
- Publication number
- JP2023507033A5 JP2023507033A5 JP2022538373A JP2022538373A JP2023507033A5 JP 2023507033 A5 JP2023507033 A5 JP 2023507033A5 JP 2022538373 A JP2022538373 A JP 2022538373A JP 2022538373 A JP2022538373 A JP 2022538373A JP 2023507033 A5 JP2023507033 A5 JP 2023507033A5
- Authority
- JP
- Japan
- Prior art keywords
- mutations
- domain
- polypeptide
- protein complex
- numbering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951701P | 2019-12-20 | 2019-12-20 | |
| US62/951,701 | 2019-12-20 | ||
| PCT/CA2020/051753 WO2021119832A1 (en) | 2019-12-20 | 2020-12-18 | Polypeptides, protein complexes and method for making same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023507033A JP2023507033A (ja) | 2023-02-20 |
| JP2023507033A5 true JP2023507033A5 (cg-RX-API-DMAC7.html) | 2023-12-27 |
Family
ID=76476896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538373A Pending JP2023507033A (ja) | 2019-12-20 | 2020-12-18 | ポリペプチド、タンパク質複合体及びそれを作製する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230242676A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4077374A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023507033A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115003693A (cg-RX-API-DMAC7.html) |
| AR (1) | AR120870A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3171363A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI907375B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021119832A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240350588A1 (en) * | 2021-08-24 | 2024-10-24 | Sunshine Lake Pharma Co., Ltd. | Gdf15 fusion proteins and use thereof |
| EP4400512A4 (en) * | 2021-09-10 | 2025-07-23 | Soter Biopharma Pte Ltd | ANTI-ANG2 ANTIBODY, ITS PREPARATION METHOD AND ITS USE |
| MX2024003779A (es) | 2021-09-29 | 2024-04-19 | Kisoji Biotechnology Inc | Agentes de union dirigidos a celulas tumorales que expresan trop2. |
| WO2023088295A1 (zh) * | 2021-11-17 | 2023-05-25 | 江苏先声药业有限公司 | 一种多特异性抗体及其药物用途 |
| EP4599066A1 (en) * | 2022-10-03 | 2025-08-13 | Kisoji Biotechnology Inc. | Multispecific binding agents targeting dopamine receptor d2 and methods of use thereof |
| CN120265659A (zh) * | 2022-10-25 | 2025-07-04 | 加拿大商木曾路生物科技公司 | 靶向表达cd36的肿瘤细胞的结合剂 |
| KR20250112917A (ko) | 2022-12-12 | 2025-07-24 | 라노바 메디신즈 리미티드 | Pd1 및 vegf를 표적으로 하는 이중특이적 항체 |
| EP4688866A1 (en) * | 2023-04-04 | 2026-02-11 | Kisoji Biotechnology Inc. | Binding agents targeting trop2-expressing tumor cells |
| EP4520768A1 (en) * | 2023-09-06 | 2025-03-12 | BioNTech SE | Vhh-ch3 fusion proteins |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013012733A1 (en) * | 2011-07-15 | 2013-01-24 | Biogen Idec Ma Inc. | Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto |
| US9527927B2 (en) * | 2011-12-20 | 2016-12-27 | Medimmune, Llc | Modified polypeptides for bispecific antibody scaffolds |
| WO2015048272A1 (en) * | 2013-09-25 | 2015-04-02 | Amgen Inc. | V-c-fc-v-c antibody |
| CN110981957B (zh) * | 2014-01-15 | 2024-12-24 | 豪夫迈·罗氏有限公司 | 具有改善的蛋白A结合作用的Fc区变体 |
| SG10201913507SA (en) * | 2014-05-02 | 2020-02-27 | Momenta Pharmaceuticals Inc | Compositions and methods related to engineered fc constructs |
| JP6966330B2 (ja) * | 2015-05-01 | 2021-11-17 | インヒブルクス,インコーポレイティド | Iii型分泌装置標的化分子 |
| WO2016192613A1 (zh) * | 2015-06-01 | 2016-12-08 | 中山大学 | 具有融合至常规Fab片段的单域抗原结合片段的二价抗体 |
| JP7328761B2 (ja) * | 2016-01-11 | 2023-08-17 | インヒブルクス インコーポレイテッド | 多価多重特異性ox40結合融合タンパク質 |
| IL304871A (en) * | 2016-01-11 | 2023-10-01 | Inhibrx Inc | Multispecific and multivalent binding fusion proteins - 41BB, preparations containing them and their uses |
| DK3529269T3 (da) * | 2016-10-19 | 2026-02-23 | Invenra Inc | Antistof-konstruktioner |
| JP7543134B2 (ja) * | 2017-10-03 | 2024-09-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | システイン操作された抗原結合分子 |
| CN111836832A (zh) * | 2018-01-08 | 2020-10-27 | 南京传奇生物科技有限公司 | 多特异性抗原结合蛋白及其使用方法 |
| EP3773621A4 (en) * | 2018-03-27 | 2022-03-23 | Systimmune, Inc. | GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHODS FOR THEIR MANUFACTURE AND USE |
-
2020
- 2020-12-18 CA CA3171363A patent/CA3171363A1/en active Pending
- 2020-12-18 EP EP20902077.5A patent/EP4077374A4/en active Pending
- 2020-12-18 CN CN202080094676.5A patent/CN115003693A/zh active Pending
- 2020-12-18 US US17/786,708 patent/US20230242676A1/en active Pending
- 2020-12-18 WO PCT/CA2020/051753 patent/WO2021119832A1/en not_active Ceased
- 2020-12-18 JP JP2022538373A patent/JP2023507033A/ja active Pending
- 2020-12-21 TW TW109145364A patent/TWI907375B/zh active
- 2020-12-21 AR ARP200103608A patent/AR120870A1/es unknown